Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate and Thiotepa in Primary CNS Lymphoma
NCT00045539Phase 2Completed
- Sponsor
- New Approaches to Brain Tumor Therapy Consortium
- Start
- Oct 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, thiotepa in primary central nervous system lymphoma (PCNSL), sponsored by New Approaches to Brain Tumor Therapy Consortium. Started Oct 2002; status: completed.
02
Drugs
methotrexatethiotepa
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00045539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045539.